RNA-mediated therapies in myotonic dystrophy - ScienceDirect
Epigenetics of the myotonic dystrophy-associated DMPK gene neighborhood | Epigenomics
DMPK gene. The DMPK gene is located in chromosome 19 at the q13.32... | Download Scientific Diagram
Mutation analysis of multiple pilomatricomas in a patient with myotonic dystrophy type 1 suggests a DM1-associated hypermutation phenotype | PLOS ONE
Cardiac Involvement and Arrhythmias Associated with Myotonic Dystrophy
Processing of DMPK and DMAHP genes within normal and DM cells. In the... | Download Scientific Diagram
Myopathies without EOM Weakness: Facioscapulohumeral + Myotonic Dystrophy
Genetic alteration of Steinert's myotonic dystrophy
Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1 | Gene Therapy
Epigenetics and Myotonic Dystrophy Type 1 | Encyclopedia MDPI
IJMS | Free Full-Text | Correction of RNA-Binding Protein CUGBP1 and GSK3β Signaling as Therapeutic Approach for Congenital and Adult Myotonic Dystrophy Type 1
Congenital and childhood myotonic dystrophy: Current aspects of disease and future directions
Genetics of Myotonic Dystrophy (MD) and Fascioscapulohumeral Dystrophy (FSHD) - Educational Resources - National Registry for Myotonic Dystrophy (DM) and Facioscapulohumeral Dystrophy (FSHD) - Neurology - University of Rochester Medical Center
Two hypotheses on interaction of toxic RNA from mutated DMPK gene. I:... | Download Scientific Diagram
Kill the messenger where it lives | Nature
Transcriptional abnormality in myotonic dystrophy affects DMPK but not neighboring genes | PNAS
DMPK gene. The DMPK gene is located in chromosome 19 at the q13.32... | Download Scientific Diagram
Molecular genetic and clinical characterization of myotonic dystrophy type 1 patients carrying variant repeats within DMPK expansions | SpringerLink
Deconstructing Myotonic Dystrophy | Science
Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells: Molecular Therapy - Nucleic Acids
Aberrant Myokine Signaling in Congenital Myotonic Dystrophy - ScienceDirect
A CRISPR‐Based Selective Gene Inhibition Method Reveals Dynamic Features of a Cell Nucleus Nanobody Related to the Disease Myotonic Dystrophy - Ma - 2018 - Small Methods - Wiley Online Library
Myotonic Dystrophy Type 2 - Home
![PDF] Myotonic Dystrophy Protein Kinase: Structure, Function and Its Possible Role in the Pathogenesis of Myotonic Dystrophy Type 1 | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e76854a6ec9f44f6d8e3b256cc9e21d0fec466e2/3-Figure1-1.png "PDF] Myotonic Dystrophy Protein Kinase: Structure, Function and Its Possible Role in the Pathogenesis of Myotonic Dystrophy Type 1 | Semantic Scholar")
PDF] Myotonic Dystrophy Protein Kinase: Structure, Function and Its Possible Role in the Pathogenesis of Myotonic Dystrophy Type 1 | Semantic Scholar
Genome Editing of Expanded CTG Repeats within the Human DMPK Gene Reduces Nuclear RNA Foci in the Muscle of DM1 Mice: Molecular Therapy
